A tale of two stimulants: Mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence☆
Introduction
In 2009, the Family Smoking Prevention and Tobacco Control Act granted the Food and Drug Administration (FDA) regulatory power over particular aspects of tobacco products, including flavor additives (Family Smoking Prevention and Tobacco Control Act, 2009). Since that time, the FDA has banned flavored cigarettes, with the exception of mentholated cigarettes, and commissioned an advisory committee to report on the impact that mentholated cigarettes have on public health (Benowitz and Samet, 2011). The report from the advisory committee noted that, while there is not conclusive evidence to suggest that menthol, relative to non-menthol, cigarette smokers have worse disease outcomes, there is evidence that mentholated cigarettes lead to more smoking initiation and greater difficulty with smoking cessation and, thus, public health would benefit from the elimination of mentholated cigarettes (Benowitz and Samet, 2011). However, there has been reluctance to ban menthol cigarettes based on concern that such a ban would lead to a black market for menthol cigarettes (Carter, 2013). Additional data on the potential impact of mentholated cigarettes on public health would be helpful in weighing the potential costs and benefits of banning them.
A potential negative impact of mentholated cigarettes that has received minimal attention is their potential role in cocaine dependence. Cocaine dependence represents a significant problem as evidenced by the sheer number of lives affected, its associated medical and legal consequences, and the difficulty finding effective treatments (Winhusen et al., 2007). The scope of the cocaine problem is largely attributed to the advent of crack, an inexpensive, smokable and, thus, particularly addictive form of cocaine, in the mid-1980s. In 2010, over one million people in the United States were abusing or dependent on cocaine (Substance Abuse and Mental Health Services Administration (SAMHSA), 2011). Because psychosocial interventions are associated with high relapse rates, an impressive amount of resources have been devoted to finding pharmacological treatments that could be used in conjunction with psychosocial treatments; yet there still is no widely used, safe and effective treatment for cocaine dependence (Kuehn, 2009). A link between cigarette smoking and cocaine abuse has been established in both clinical and laboratory studies. The rate of smoking in cocaine abusers is 75–80% (Budney et al., 1993, Sees and Clark, 1993, Gorelick et al., 1997) and smoking cigarettes is associated with more severe cocaine dependence, including more frequent cocaine use, a greater likelihood of injecting or smoking cocaine, and more severe employment and legal difficulties (Budney et al., 1993, Roll et al., 1997). Human laboratory studies have found that cocaine administration increases the rate of cigarette smoking (Nemeth-Coslett et al., 1986, Roll et al., 1996), and that mecamylamine, a nicotine antagonist, reduces cue-induced cocaine craving (Reid et al., 1999) while nicotine increases it (Reid et al., 1998).
Menthol has been shown to enhance transdermal and transbuccal absorption of other drugs (Ahijevych and Garrett, 2004). It has been posited that, when inhaled, menthol may increase the permeability of drugs in the lungs as well, thereby increasing the pulmonary absorption of constituents found in smoke (Ahijevych and Garrett, 2004, Clark et al., 1996). If used together with other substances of abuse, menthol may enhance the reinforcing effects of other substances by affecting the calcium conductance of cells involved in drug reinforcement (Clark et al., 1996). Research suggests that the association between cigarette and cocaine use may be more pronounced for patients who smoke mentholated cigarettes. Specifically, Sees and Clark interviewed cocaine-dependent patients about their cigarette and cocaine use to better understand why these behaviors co-occur at such high rates (1993). In the course of these interviews, participants noted that mentholated cigarettes prolong the cocaine high, allow them to smoke crack for longer periods due to the cooling effects of menthol, and even produce feelings similar to the effects of cocaine in the absence of cocaine use (Sees and Clark, 1993). Consistent with this report, a small study by Wiseman and McMillan found that cocaine-dependent participants preferring mentholated cigarettes cited the ability of menthol to make the cocaine high last longer and as a substitute for cocaine among the reasons for their preference (1998). Wiseman and McMillan (1998) hypothesized that irritants in menthol cigarettes may increase lung permeability increasing exposure to smoked cocaine. If menthol increases the subjective effects of cocaine then one might expect greater dependence severity, as indicated by more difficulty abstaining from cocaine, in cocaine-dependent patients using menthol, relative to non-menthol, cigarettes.
A recent multi-site trial conducted by the National Institute on Drug Abuse (NIDA) National Drug Abuse Treatment Clinical Trials Network (CTN) evaluated the impact of concurrent substance use disorder (SUD) and nicotine dependence treatment for cocaine and/or methamphetamine-dependent patients who were also nicotine dependent. The present study utilized this dataset to explore the potential role of mentholated cigarettes in cocaine dependence. Specific aims included evaluating participants’ reasons for using cocaine and cigarettes together, the relative level of cocaine dependence severity, and success in achieving smoking cessation, all as a function of cigarette type (i.e., menthol vs. non-menthol). It was predicted that menthol, relative to non-menthol, cocaine-dependent cigarette smokers would be more likely to report that cigarettes prolong the cocaine high, and would be less likely to be illicit-stimulant abstinent and to achieve smoking cessation. Finally, while smoking rates are estimated to be 87% or higher in methamphetamine abusers (Grant et al., 2008, Weinberger and Sofuoglu, 2009), past research has not evaluated the potential role of mentholated cigarettes in methamphetamine; completing an initial evaluation of a potential relationship was an aim of the present study.
Section snippets
Study design
Details of the clinical trial are provided elsewhere (Winhusen et al., 2012a, Winhusen et al., in press). Briefly, the study was a 10-week, two-group, randomized trial to evaluate the impact of providing smoking cessation treatment (SCT) with SUD treatment as usual (TAU), compared to TAU alone, in smokers who are in outpatient treatment for cocaine or methamphetamine dependence. Eligible participants were randomized to TAU or TAU + SCT in a 1:1 ratio. Follow-up visits were completed at 3 and 6
Participants
Demographic and baseline characteristics are provided in Table 1. Of the 301 cocaine-dependent participants, 201 (67%) were menthol and 100 (33%) were non-menthol cigarette smokers. Of the 209 methamphetamine-dependent participants only 33 (16%) were menthol cigarette smokers. The cocaine-dependent menthol and non-menthol cigarette smokers differed significantly on race and ethnicity, which is consistent with the greater prevalence of menthol smokers in African Americans (Giovino et al., 2004,
Discussion
The present study sought to replicate and expand upon prior reports of a connection between menthol cigarette and cocaine use while completing an initial evaluation of the relationship between menthol cigarettes and methamphetamine use. While cocaine and methamphetamine are both stimulants, the present results suggest that mentholated cigarettes may play a role in cocaine dependence but not in methamphetamine dependence. Specifically, the present results revealed that cocaine-dependent
Role of funding source
Funding for this study was provided by the National Institute on Drug Abuse (NIDA) Clinical Trials Network: U10-DA013732 to University of Cincinnati (Dr. Winhusen); U10-DA020036 to University of Pittsburgh (Dr. Daley), U10-DA013720 to University of Miami School of Medicine (Drs. Szapocznik and Metsch); U10-DA013045 to University of California Los Angeles (Dr. Ling); U10-DA013727 to Medical University of South Carolina (Dr. Brady); U10-DA020024 to University of Texas Southwestern Medical Center
Contributors
Dr. Winhusen conceptualized the research hypotheses, contributed to the analysis and interpretation of the data, and led the drafting of the manuscript. Mr. Lewis conducted analyses and critically reviewed the manuscript. Dr. Adinoff, Dr. Brigham, Dr. Gardin, Dr. Sonne, Mr. Theobald, and Dr. Ghitza contributed to the interpretation of the findings and critically revised the manuscript for important intellectual content. All authors have approved the final manuscript.
Conflict of interest
The authors have no potential conflicts of interest to report.
References (37)
- et al.
Nicotine and caffeine use in cocaine-dependent individuals
J. Subst. Abuse
(1993) - et al.
Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers
Chest
(1996) - et al.
Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects
Pharmacol. Biochem. Behav.
(2005) - et al.
An acute dose of nicotine enhances cue-induced cocaine craving
Drug Alcohol Depend.
(1998) - et al.
A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects
Neuropsychopharmacology
(1999) - et al.
A comparison of cocaine-dependent cigarette smokers and non-smokers on demographic, drug use and other characteristics
Drug Alcohol Depend.
(1996) - et al.
When to begin smoking cessation in substance-abusers
J. Subst. Abuse Treat.
(1993) - et al.
A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence
Drug Alcohol Depend.
(2007) - et al.
Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals
Contemp. Clin. Trials
(2012) - et al.
The potential impact of recruitment method on sample characteristics and treatment outcomes in a psychosocial trial for women with co-occurring substance use disorder and PTSD
Drug Alcohol Depend.
(2012)
Rationale for cigarette smoking and for mentholation preference in cocaine- and nicotine-dependent outpatients
Compr. Psychiatry
Menthol pharmacology and its potential impact on cigarette smoking behavior
Nicotine Tob. Res.
Occupational status, work-site cessation programs and policies and menthol smoking on quitting behaviors of US smokers
Addiction
Sociocultural correlates of menthol cigarette smoking among adult African Americans in Los Angeles
Nicotine Tob. Res.
The threat of menthol cigarettes to U.S. public health
N. Engl. J. Med.
Mentholated cigarette smoking inhibits nicotine metabolism
J. Pharmacol. Exp. Ther.
Commentary on Nonnemaker et al. (2013): banning menthol cigarettes – is it time to conduct the experiment?
Addiction
Statistical Power Analysis for the Behavioral Sciences
Cited by (14)
A latent class analysis of the past-30-day substance use patterns among lifetime cocaine users: Findings from a community sample in North Central Florida
2019, Addictive Behaviors ReportsCitation Excerpt :Though national studies provide an overview of prevalence rates, community data provide information on burdens of substance use within specific geographic regions and are valuable for the design and implementation of local interventions to address community needs. Previous studies have shown that cocaine users concurrently use other substances frequently, including alcohol (Blow et al., 2011; Borders & Booth, 2013; Evans-Polce, Lanza, & Maggs, 2016; Hedden, Malcolm, & Latimer, 2009; Liu, Williamson, Setlow, Cottler, & Knackstedt, 2018), tobacco (Winhusen et al., 2013), marijuana (Gonçalves & Nappo, 2015; Liu et al., 2018), heroin (Leeman, Sun, Bogart, Beseler, & Sofuoglu, 2016; Ojha, Sigdel, Meyer-Thompson, Oechsler, & Verthein, 2014; Oviedo-Joekes et al., 2015), and prescription medications (Al-Tayyib, Rice, Rhoades, & Riggs, 2014; Chen et al., 2014; Evans-Polce et al., 2016; Herman-Stahl, Krebs, Kroutil, & Heller, 2006; Winhusen et al., 2013). Polysubstance users have been found to have a higher risk of overdose, emergency department (ED) visits, violence, accidental injury (Macdonald et al., 2014), traffic accidents (De Boni et al., 2014), and lower addiction treatment effectiveness (Evans et al., 2015; Hou, Zhan, Zheng, Zhan, & Zheng, 2014; Liu et al., 2018) compared to mono-substance users.
Menthol cigarette smoking among individuals in treatment for substance use disorders
2018, Addictive BehaviorsCitation Excerpt :Inquiry into possible pharmacological interactions between menthol and marijuana is merited. High prevalence of menthol smoking among individuals in treatment for cocaine use was previously reported (Winhusen et al., 2013). A qualitative study of cocaine users who smoke cigarettes found that menthol smokers reported increased sensorimotor or stimulating effects as a frequent reason for why they preferred menthol versus non-menthol cigarettes (Wiseman & McMillan, 1998).
Binge drinking and marijuana use among menthol and non-menthol adolescent smokers: Findings from the Youth Smoking Survey
2014, Addictive BehaviorsCitation Excerpt :Similarly, it is well documented that marijuana use is associated with several adverse outcomes such as cardiovascular disease, impaired respiratory function, development of a dependence syndrome, increased risk of motor vehicle accidents, and the negative effects of regular use on adolescent mental health (Hall & Degenhardt, 2009). There is a growing concern that menthol smoking may stimulate other health risk behavior (Kong, Singh, Camenga, Cavallo, & Krishnan-Sarin, 2013; Winhusen et al., 2013). Tobacco companies have continually exploited the sensory characteristics of menthol cigarettes in order to reinforce smoking behavior and addiction among youth and beginning smokers (Anderson, 2011; Lee & Glantz, 2011).
Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment
2014, Drug and Alcohol DependenceCitation Excerpt :The present analyses evaluated the association between achieving smoking abstinence and illicit-stimulant abstinence in the post-smoking-quit phase of the study for participants randomized to the smoking-cessation condition. Because there are important differences between cocaine and methamphetamine (Newton et al., 2005; Winhusen et al., 2013a,b), we evaluated the association for the entire sample as well as separately for the cocaine-dependent and methamphetamine-dependent participants. Details of the trial are provided elsewhere (Winhusen et al., 2012a).
Assessing the evidence on the differential impact of menthol versus non-menthol cigarette use on smoking cessation in the U.S. population: a systematic review and meta-analysis
2021, Substance Abuse: Treatment, Prevention, and Policy
- ☆
Trial registration: Clinical Trials.gov http://www.clinicaltrials.gov; Identifier: NCT01077024.